FDA drafts guidance on follow up testing for drug candidates with mutagenic potential
Regulatory NewsFerdous Al-Faruque
GuidancePharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsFerdous Al-FaruqueGuidancePharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)